SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1411emphasis mine..... Aliment Pharmacol Ther 2002 Apr;16(4):699-705 A pilot studyscaram(o)uche-4/7/2002
1410I think this may be right. $30 is very possible. If Amevive does not make it, Harold Engstrom-4/7/2002
1409BGEN Biogen, Inc. $ 53.68 pretty boring, but it has been pretty boring since AAxxel-4/7/2002
1408Well a recommendation to approve Amevive will make the other questions fade. Thaknahow-4/4/2002
1407Gw, Bottom line: Amevive approval yes or not, the rest is just discoloration froCacaito-4/4/2002
1406The next ELN or BMY or even IMCL? It is easy to dump on a company once their aaknahow-4/4/2002
1405Gw, the "briefing report" of meetings are available to the public ONE Cacaito-4/3/2002
1404Like the "pebble",the flares keep bringing then back...that is why XanCacaito-4/3/2002
1403Gw, there is a "pre-meeting report" that is published at the Fda WebsiCacaito-4/3/2002
1402Cacaito thanks, appreciated your response and the story. what you propose couldaknahow-4/2/2002
1401Jason, Do you mean May 23, pr on April 1st !!!Cacaito-4/2/2002
1400Drop out rate higher in the ones that got better, classic response of subjects wCacaito-4/2/2002
1399I guess this makes it official, but it is April 1... Jason <i>Monday Aprtnsaf-4/1/2002
1398Never heard of pre meetings. Can you explain? IMO Fulcrum is wrong and Amevivaknahow-4/1/2002
1397Fulcrum expects Fda non-approval for Amevive. A "sell" recommedation oCacaito-4/1/2002
1396From Briefing,which is clearly not impressed by the Boston Globe: <i>07:1tom pope-3/28/2002
1395When will the FDA respond to Biogen's Amevive filing? BGEN says shareholderaknahow-3/22/2002
1394marketwatch.com Article for anyone interested in Serano nd or BGEN.aknahow-3/13/2002
1393[ Latest Headlines | Market Overview | News Alerts | More Reuters Securities ] aknahow-3/12/2002
1392Thanks, BTW I had not hear the Menter and Roenigk lectures provided at this otheaknahow-3/9/2002
1391George: <i>Never found your post of the Krueger link. </i> Here weBiomaven-3/9/2002
1390Never found your post of the Krueger link. It was not a year old so perhaps youaknahow-3/9/2002
1389Anyone listen to the BGEN conference call on 26 Feb.?aknahow-2/27/2002
1388They are a bit dated, believe they are from a June 2001 meeting. If you posted aknahow-2/26/2002
1387George, Note that the Kruger psoriasis lecture, although great, is a little datBiomaven-2/26/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News